Distinguished Award & Outstanding Young Physician Award 2018

The Royal College of Physicians of Thailand (RCPT) would like to invite Regular members of Physician, Hospital Director and Provincial Public Health Physicians to distinguish the Award and Outstanding Young Physician Award 2018 from now until 1st October 2017.   Physician Award & Outstanding Young Physician Award established since 2004 (Toward into the 15th year of the awards). The Purpose of the Awards is honor the Physicians who work hard, determine, sacrifice, ethical and to be a role model of Physician.   Download http://www.rcpt.org/content/2560/outstanding_doctor_2561/

Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas.

Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas. J Clin Endocrinol Metab 90: 5566?5575, 2005 ปี 2548 Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas. C. A. Spencer, L. M. Bergoglio, M. Kazarosyan, S. Fatemi, and J. S. LoPresti Context: Changes in thyroglobulin (Tg) and/or Tg antibody (TgAb) methods can disrupt the serial monitoring of differentiated thyroid carcinoma (DTC) patients. Objective: This study compared Tg measurements made in TgAb negative and TgAb-positive sera using four RIA and 10 immunometric assay (IMA) methods. Design: TgAb detection using a panel of 12 direct methods was contrasted with four Tg recovery tests. Sera from 110 normal euthyroid subjects (68 TgAb negative/42 TgAb positive) and 131 TgAbnegative DTC patients had Tg and/or TgAb analyses made by 10 laboratories in four countries. Euthyroid controls were used to compare Tg and TgAb ranges, sensitivities, […]

Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis

Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis2005 90: 5723-5729 ปี 2548   Sophie Leboulleux, Carole Rubino, Eric Baudin, Bernard Caillou, Dana M. Hartl, Jean-Michel Bidart,Jean-Paul Travagli and Martin Schlumberger Departments of Nuclear Medicine and Endocrine Tumors (S.L., E.B., M.S.), Institut National de la Santé et de la Recherche Médicale U605 (C.R.), Pathology (B.C.), Surgical Oncology (J.-P.T., D.M.H.), and Clinical Biology (J.-M.B.), Institut Gustave Roussy, 94805 Villejuif Cédex, France   Context: Reliable prognostic factors are needed in papillary thyroid cancer patients to adapt initial therapy and follow-up schemes to the risks of persistent and recurrent disease.  Objective and Settings: To evaluate the respective prognostic impact of the extent of lymph node (LN) involvement and tumor extension beyond the thyroid capsule, we studied a group of 148 consecutive papillary thyroid cancer patients with LN metastases and/or extrathyroidal tumor extension. Initial treatment, performed at the Institut Gustave Roussy between 1987 […]